Sign in Subscribe
Microbial drug resistance

World Health Organization Identifies 40 Research Priorities to Address Antimicrobial Resistance

Strategic Insights

— 1 min read

The World Health Organization (WHO) has identified 40 research priorities to address antimicrobial resistance (AMR) in human health by the year 2030. These priorities focus on bacterial and fungal pathogens causing tuberculosis and other critical diseases. The research agenda aims to encourage investment in generating evidence to understand AMR dynamics and reduce its burden.

Key Takeaways:

  • The WHO research agenda for antimicrobial resistance has identified 40 research priorities to be addressed by 2030.
  • These priorities focus on bacterial and fungal pathogens, including those causing tuberculosis.
  • The research agenda encompasses the entire people-centred journey, covering prevention, diagnosis, treatment, and addressing knowledge gaps in AMR epidemiology, burden, drivers, policies, and regulations.
  • The priority setting involved a multistage process, including a comprehensive scoping review, expert inputs, and a survey and open call.
  • The ultimate goal of this research agenda is to facilitate policy translation for reducing the burden and consequences of AMR.
  • Additional authors on this research include Zlatina Dobreva, Chad M. Centner, Ioana Diana Olaru, Daniele Dona, Stefano Burzo, Benedikt D. Huttner, Antoine Chaillon, Nebiat Gebreselassie, Teodora Wi, Mateusz Hasso-Agopsowicz, Benedetta Allegranzi, Hatim Sati, Verica Ivanovska, and K.

Statistics:

  • 40 research priorities have been identified by the WHO to address antimicrobial resistance in human health by 2030.
  • The research priorities focus on bacterial and fungal pathogens, including those causing tuberculosis.
  • 2030 is the target year for addressing the identified research priorities.
  • The research agenda covers prevention, diagnosis, and treatment of antimicrobial-resistant infections.

Sources:

  • TOC 10/105/410
  • Wang et al. Effects of antimicrobial peptides on multidrug-resistant bacteria. Peptides, 21(10), 1443-1452. doi:10.1016/j.peptides.2002.03.019
  • WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe, 2024:100902.
  • NewsRx. World Health Organization (WHO) Reports Findings in Antimicrobials (WHO global research priorities for antimicrobial resistance in human health). Politics & Government Week. August 29, 2024; p 422.

Read more